Kauh John Saewook M.D. has filed 4 insider transactions across 1 company since April 2025.
Most recent transaction: a grant/award of 45000 shares of Tvardi Therapeutics, Inc. ($TVRD) on January 29, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 29, 2026 | Tvardi Therapeutics, Inc. | $TVRD | Kauh John Saewook M.D. | Chief Medical Officer | A | Employee Stock Option (right to buy) | 45000 | $0.00 | 45,000.0000 | 9,377,079 | 9999.99% | 0.48% |
| Dec. 16, 2025 | Tvardi Therapeutics, Inc. | $TVRD | Kauh John Saewook M.D. | Chief Medical Officer | A | Employee Stock Option (right to buy) | 17500 | $0.00 | 17,500.0000 | 9,377,079 | 9999.99% | 0.19% |
| April 17, 2025 | Tvardi Therapeutics, Inc. | $TVRD | Kauh John Saewook M.D. | Chief Medical Officer | A | Employee Stock Option (right to buy) | 36210 | $0.00 | 36,210.0000 | 1,524,116 | 9999.99% | 2.38% |
| April 15, 2025 | Tvardi Therapeutics, Inc. | $TVRD | Kauh John Saewook M.D. | Chief Medical Officer | A | Employee Stock Option (right to buy) | 74049 | $0.00 | 74,049.0000 | 1,524,116 | 9999.99% | 4.86% |